Neurogene Inc. (NGNE)
NASDAQ: NGNE · Real-Time Price · USD
14.52
-0.81 (-5.28%)
At close: Mar 28, 2025, 4:00 PM
14.59
+0.07 (0.45%)
After-hours: Mar 28, 2025, 6:55 PM EDT
Neurogene Market Cap
Neurogene has a market cap or net worth of $216.78 million as of March 28, 2025. Its market cap has increased by 155.94% in one year.
Market Cap
216.78M
Enterprise Value
-83.20M
1-Year Change
155.94%
Ranking
Category
Stock Price
$14.52
Market Cap Chart
Since March 7, 2014, Neurogene's market cap has increased from $114.10M to $216.78M, an increase of 89.99%. That is a compound annual growth rate of 5.97%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 28, 2025 | 216.80M | -36.16% |
| Dec 31, 2024 | 339.60M | 646.37% |
| Dec 29, 2023 | 45.50M | 109.68% |
| Dec 30, 2022 | 21.70M | -89.39% |
| Dec 31, 2021 | 204.50M | -65.38% |
| Dec 31, 2020 | 590.70M | 25.07% |
| Dec 31, 2019 | 472.30M | 829.72% |
| Dec 31, 2018 | 50.80M | -81.59% |
| Dec 29, 2017 | 275.90M | -28.65% |
| Dec 30, 2016 | 386.70M | 80.03% |
| Dec 31, 2015 | 214.80M | 167.83% |
| Dec 31, 2014 | 80.20M | -29.71% |
View and export this data all the way back to 2014.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 741.59B |
| UnitedHealth Group | 473.86B |
| Johnson & Johnson | 394.20B |
| AbbVie | 359.81B |
| Novo Nordisk | 308.71B |
| Abbott Laboratories | 228.71B |
| AstraZeneca | 225.00B |
| Merck & Co. | 223.20B |